An. Chiang et al., CHANGES IN PLASMA-LEVELS OF LIPIDS AND LIPOPROTEIN COMPOSITION IN PATIENTS WITH KAWASAKI-DISEASE, Clinica chimica acta, 260(1), 1997, pp. 15-26
Studies on the response of plasma lipids and lipoproteins to Kawasaki
disease are scarce so far. The purpose of this study was to investigat
e the changes in plasma levels of lipids and apolipoproteins as well a
s the composition of different lipoproteins in patients during the acu
te and convalescence phases of Kawasaki disease. The results showed th
at during the acute phase, the concentrations of plasma high density l
ipoprotein (HDL)-cholesterol, apolipoprotein A-I (apoA-I) and A-Il (ap
oA-II) were significantly reduced. While the reduction of HDL-choleste
rol was mainly related to the lowering of esterified and unesterified
cholesterols in HDL(2) during the acute stage of Kawasaki disease, mos
t of which recovered during the subsequent convalescence phase. The pl
asma concentration of triglycerides was 46% higher in patients during
the acute phase of Kawasaki disease than in the control subjects, whic
h may be ascribed to the increase of triglycerides in very low density
lipoprotein (VLDL), low density lipoprotien (LDL) and HDL(2). The var
iables studied above did not appear to be independent parameters. The
level of plasma apoA-I showed a stronger negative association with tri
glyceride concentration (r = - 0.22) than apoA-II (r = - 0.11) and HDL
-cholesterol (r = - 0.07). Furthermore, the levels of cholesterol, apo
A-I and apoA-II in HDL(2), but not in HDL(3), were inversely correlate
d with the levels of triglyceride. We conclude that the temporary chan
ges of lipid levels associated with Kawasaki disease results predomina
ntly from alterations of lipoprotein composition. (C) 1997 Elsevier Sc
ience B.V.